The medication works by enhancing insulin secretion, suppressing glucagon release, and slowing gastric emptying, as described in the FDA-approved prescribing information
A more strategic clinical decision is to maintain the GLP-1 at a tolerable maintenance dose to control appetite, and introduce a complementary mechanism
This is a unique cryodesiccation (dehydration) process, where the peptides are frozen and then subjected to a low pressure vacuum
Melanotan I is also more selective than melanotan II, only really affecting the melanocortin-1 receptor
Further, this off-label use of Ozempic is greatly impacting the availability of the medication for those who need it most. Beyond the physical impact, Janet Lydecker, PhD, an assistant professor of psychiatry at the Yale School of Medicine, noted that if people experience quick weight loss, it can lead to more weight bias and disordered eating
Now, why do we do that